Culture of human peripheral blood lymphocytes with gram-negative bacteria associated with periodontal disease caused a rapid increase in the cytotoxic potential of natural killer (NK) cells. The NK cells were activated to kill NK-resistant targets, the peak cytotoxicity occurring on day 1 of culture. The addition of anti-Tac, anti-CD3, or anti-OKT-11 antibodies to block activation via the interleukin-2 (IL-2), T-cell, or E rosette receptors had a minimal effect on this inductive process. Anti-IL-2 antiserum was effective in blocking a significant amount, but not all, of the cytotoxicity in bacterium-activated cultures. Modest IL-2 production (5 to 6 National Institutes of Health units) was measured in lymphocyte cultures activated by bacteria, but proliferation was not induced during a 1-week period. When polymixin B sulfate was added to bind and block lipopolysaccharides, bacterium-induced cytotoxicity was completely abrogated for all activating bacteria. In addition, when culture supernatants from ActinobaciUlus actinomycetemcomitans were tested, activation still occurred. However, again, this activation was totally inhibited by polymixin B sulfate. Monocytes were also activated by bacteria to produce tumor necrosis factor (TNF). To exclude the possibility that TNF was responsible for cytotoxicity, an antiserum to TNF was added to cocultures of bacteria and lymphocytes with adherent cells removed. The antiserum had no effect on the inductive process. In addition, exogenous TNF did not kill M14 targets. These results suggest that bacterial cell surface lipopolysaccharides provide a major activation signal for NK cells to enhance cytotoxicity.
Considerable interest has been focused on activated cytotoxic human lymphocytes and their role as immunologic defense cells. Peripheral blood lymphocytes can be induced by interleukin-2 (IL-2) to develop into cytotoxic cells called lymphokine-activated killers capable of lysing a wide variety of tumor cell lines and fresh tumors (8) . In addition to generation by lymphokines, activated killer cells have been generated from mixed lymphocyte culture (5, 27) , in the presence of lectins (3) , and from the stimulation of viruses (22) .
Bacteria and bacterial products also potentiate killing by lymphocytes (11, 31) . Recently, it was demonstrated that Salmonella strains which were fixed with glutaraldehyde enhance lymphocyte cytotoxicity against natural killer (NK)-sensitive and NK-resistant target cells in a manner comparable with induction by IL-2 (29) . The cell types responding to the inductive effects of glutaraldehyde-fixed Salmonella strains were CD16+ (Leu-11) and . Phillips and Lanier (23) have proposed that NK cells bearing these surface markers mediate a majority of lymphokineactivated killer activity against NK-resistant cell lines and fresh tumors.
Gram-negative bacteria associated with periodontal disease also mediate NK activation (R. A. Lindemann, K. T. Miyasaki, and L. E. Wolinsky, J. Dent. Res., in press). This finding suggests that NK cells may play a role in antimicrobial defense. However, the mechanism or pathway whereby whole bacteria activate NK cells is not known. Tarkkanen et al. (28) demonstrated that protein synthesis, but not DNA synthesis, is required for lymphocyte activation by Salmonella bacteria and that both the induction and effector phases of activation are radioresistant. The same authors also concluded that the activation can be independent of interferon release, and no changes are observed in HLA-DR, transferrin receptor, or IL-2 receptor expression. Kinetics studies with periodontal bacteria revealed that bacterial activation and IL-2 activation were significantly different over a 1-week period. Bacterium-activated lymphocyte cytotoxicity usually peaks at 1 to 2 days, while IL-2-activated lymphocyte cytotoxicity remains quite high after 7 days (Lindemann et al., in press).
It is well documented that lipopolysaccharides (LPS) from gram-negative bacteria are powerful immunostimulators (19) . However, LPS extracted from Salmonella bacteria interfered with or blocked lymphocyte activation in the presence of whole bacteria (29) . In contrast, LPS isolated from periodontal bacteria induced high levels of cytotoxicity from NK cells (Lindemann et al., in press ). The purpose of this study was to determine the role of surface LPS on glutaraldehyde-fixed whole bacteria associated with periodontal disease in the activation of human lymphocytes. In addition, the relationship between bacteria and potential NK activation pathways, the IL-2 and E rosette receptors, was investigated. (13) . Large granular lymphocytes (LGLs) were separated by a discontinuous Percoll (Pharmacia) gradient (30) .
MATERIALS AND METHODS
A panning technique was used to isolate lymphocyte subpopulations in conjunction with the monoclonal antibod- ies Leu-llb (Becton Dickinson and Co., Mountain View, Calif.) and NKH-1A (Coulter Immunology, Hialeah, Fla.). Adherent cells were first removed by plastic adherence for 1 h. The nonadherent cells were then treated separately with the monoclonal antibodies (1 p1/106 cells) and incubated on ice for 30 min. After the cells were washed twice, 3 x 106 of the antibody-treated cells were placed on tissue culture plates previously coated with an affinity-purified goat antimouse immunoglobulin M antibody (Tago, Inc., Burlingame, Calif.). After a 2-h incubation at 4°C, the nonadherent cells were removed, and then the adherent cells were gently detached by a rubber policeman.
For monocyte preparation, PBL were cultured in 24-well microdilution plates (Costar, Cambridge, Mass.) at a concentration of 2 x 106 per well in 1 ml of RPMI 1640 plus Nutridoma (Boehringer Mannheim Biochemicals, Indianapolis, Ind.), a serum-and endotoxin-free culture supplement. After cells were allowed to adhere for 1 h, nonadherent cells were vigorously washed off with warm medium. Approximately 2 x 105 adherent cells remained per well and represented >90% of monocytes, as determined by immunoperoxidase staining with a macrophage-specific monoclonal antibody (Leu-M3; Becton Dickinson). After 24 h of culture, the medium was replaced, and test bacteria were added at a 10:1 ratio of bacteria to monocyte. After a further 24 h of culture, cell-free supernatants were retrieved and assayed for tumor necrosis factor (TNF).
Bacteria. The six bacteria tested are described in Maximal release and spontaneous release are as described above for cytotoxicity assay. A specific rabbit antiserum to human TNF (as described above) was added to certain wells at a final dilution of 1:1,000 to verify that the cytotoxic activity was due to TNF and not to lymphotoxin or another cytotoxin.
Effect of TNF on M14 targets. TNF (1,000 U/ml; Cetus Corp., Emeryville, Calif.) was incubated with M14 target cells in microdilution plates for 24 h. Microdilution wells were assayed for thymidine incorporation (as described above). TNF was also incubated with chromated M14 targets for 24 h, and the spontaneous release of 51Cr was counted (as described above).
Statistics. The significance of cytotoxicity assays was determined by first converting the three effector-to-target ratios into lytic units (24) . A lytic unit is defined as the number of cells required to cause a specified amount of target lysis (in this case, 30%) and is usually expressed as lytic units per 106 lymnphocytes. This method allows a more accurate comparison between lymphocyte donors. The paired t test (two tailed) was then applied to determine the significance of lytic unit values for 30% target lysis (LU 30% in figures). strated that Salmonella bacteria activate primarily lowdensity fractions of PBL. To evaluate whether oral pathogens behaved similarly and activated LGL-rich fractions, bacteria associated with human periodontal disease were tested. Low-density fractions containing LGL (Fig.   1A , fractions 1 to 3) were highly enriched for cells activated by periodontal bacteria. Low-density fractions contained most of the NK activity. These fractions have been shown to contain a high percentage of cells bearing NK-associated antigens (29) . In contrast, fractions 4 to 7 showed minimal cytotoxic activity against M14 targets after 24 h of incubation with bacteria.
RESULTS
Phenotypic characterization of the effector cell. To determine the cell or cells activated by bacteria, panning experiments were performed to isolate lymphocyte subpopulations. Tarkkanen et al. (28) had demonstrated that Salmonella bacteria activate primarily Leu-11+ and Leu-19+ (NKH-1) lymphocyte subpopulations. To evaluate whether oral pathogens behaved similarly and activated the same cells, bacteria associated with human periodontal disease were tested. After 24 h of incubation, the vast majority of cytotoxicity against M14 targets was contained within the Leu-11+ and NKH-1+ populations (Fig. 1B) .
Results of antibody inhibition assays. To evaluate the role of NK surface receptors in the bacterial activation process, monoclonal antibodies directed against the IL-2 receptor and the E rosette receptor were tested separately. The ability of these antibodies to block cytotoxic activation by bacteria was measured in three or four subjects. All subjects responded similarly in the antibody-blocking experiments; however, there were individual differences in the levels of cytotoxic enhancement (Fig. 2) . Anti-IL-2 receptor antibody (anti-Tac) had a minimal effect on the bacterial induction of cytotoxicity by three pathogenic A. actinomycetemcomitans strains (Fig. 2A) . Antibodies against the E rosette receptor (OKT-11), which is found on some NK cells, had no effect on the cytotoxicity generated after culture with A. actinomycetemcomitans or B. gingivalis (Fig. 2B) . The possibility that bacteria activated T cells via the T-cell receptor, which would have contributed to cytotoxicity, was examined. Anti-CD3 antibody had no effect on cytotoxic development in bacterium-activated cultures (Fig. 2C) . To determine the role of IL-2 in the activation process, an antiserum to IL-2 was incubated in cocultures of bacteria and lymphocyte. This anti-IL-2 antiserum substantially blocked bacterial activation by two activating bacteria, although A. actinomycetemcomitans cultures still retained cytotoxicity above control values (Fig. 2D) . This antiserum was also effective in binding and blocking the cytotoxicity induced by exogenously added IL-2. Dilutions of antiserum above 1:1,000 had no additional effect on cytotoxicity (data not shown).
Units of IL-2 produced by activated lymphocytes. Because IL-2 antibodies substantially decreased the activation by bacteria, IL-2 was tested as a potential activation signal. IL-2 production was measured in culture supernatants by a modified enzyme-linked immunosorbent assay. Modest but significant IL-2 production above control cultures (approximately 6 National Institutes of Health units) was measured in lymphocyte cultures activated by bacteria (Table 2) . However, the cytotoxicity that developed in bacteria-lymphocyte cultures was often equivalent to 50 to 100 U of IL-2 per ml (Fig. 2) .
DNA synthesis. As IL-2 was measured in culture supernatants, its potential effects on proliferation were studied. Tarkkanen et al. (28) had demonstrated that Salmonella bacteria does not induce lymphocyte proliferation. Lymphocytes cultured in the presence of periodontal bacteria did not proliferate at any time during a 1-week period (Table 3) . Cytotoxicity, measured in conjunction with proliferation, peaked on day 1 of culture and subsequently declined. By day 7, the cytotoxicity of bacterium-treated lymphocytes was negligible compared with that of the IL-2 culture.
Effect of PB. Because IL-2 did not appear to be responsible for all the bacterium-activated cytotoxicity, the effect of LPS, a known immune-activating component of bacterial cell walls, was evaluated. The antibiotic PB was tested because of its ability to bind and neutralize the effects of LPS. PB ( Fig. 3) . Both pathogenic and nonpathogenic periodontal bacteria activated lymphocytes to kill M14 targets. PB had no effect on cytotoxicity when cultured with PBL alone or with PBL activated by IL-2.
Culture supernatants. To determine the effect of IL-2 on bacterial wall components released in culture, supernatants were collected and added to autologous lymphoc'ytes, and the mixture was incubated for 24 h. Supernatants from A. actinomycetemcomitans Y4 cultures activated PBL significantly above control cytotoxicity values (Fig. 4) . This activation was abolished by the addition of PB. Supernatants from B. gingivalis had no significant activating effect on lymphocytes.
Bacterial activation of monocytes and TNF production. Because a recent report had suggested that TNF augmented NK cytotoxicity (21) , the role of TNF in bacterial activation was studied. As LPS is a known monocyte activator, the possibility that contaminating monocytes released TNF and enhanced NK cytotoxicity or killed targets directly was considered. Monocytes were also activated by whole bacteria and released significant amounts of TNF, as measured by a cytotoxicity assay (Fig. 5) . Addition of an antiserum to TNF completely abrogated the cytotoxicity in this assay. To evaluate monocyte participation in the bacterial activation of lymphocytes, an antiserum td TNF was incubated with bacteria and lymphocytes in culture. the antiserurn had no effect on activation of lymphocytes by any bacteria tested (data not shown).
To rule out the possibility that TNF was not completely inhibited by TNF antiserum, the direct effects of TNF on M14 targets were assessed. Incubation of TNiP with M14 targets for 24 h had no effect on. proliferation (Table 4 ). In addition, M14 targets were resistant to exogenously added TNF at 1,000 U/ml.
DISCUSSION
Previous studies have indicated that granm-negative bacteria rapidly activate the cytotoxic capacity of human PBL. Bacterium-enhanced PBL cytotoxicity at 24 h was comparable with IL-2-activated cytotoxicity. However, bacterial activation peaked rapidly after 24 h of incubation, a result which contrasts markedly with the kinetics of IL-2 activation.
The results of this investigation demonstrate that lowdensity LGL fractions were substantially enriched for cells capable of activation by periodontal bacteria. Phenotypi- 5 . Bacterial activation of monocytes to produce TNF. Bacteria were added in a 10:1 bacterium-to-monocyte ratio. Antiserum to TNF (a TNF; 1:1,000) abrogated cytotoxicity. Abbreviations and symbols are as defined in the legend to Fig. 4 . (Fig. 2) . In addition, the anti-IL-2 antiserum was effective in neutralizing approximately 100 U of exogenously added IL-2, yet not all cytotoxicity was blocked in bacterium-activated cultures.
The possibility that bacteria stimulated T cells via the T-cell receptor was tested. Antibody against the T-cell receptor was added during culture to block activation via this molecule. Activation was not inhibited, which suggested that T cells did not participate in the activation phenomenon. However, in T cells, an alternative pathway of activation via the sheep erythrocyte receptor protein (Til) has also been demonstrated (15) . It has been suggested that this molecule is responsible for the polyclonal activation of T lymphocytes by a variety of bacteria and viruses (15) The present data support the observations of Tarkkanen et al. (28) , who demonstrated that DNA synthesis was not required for activation. The addition of glutaraldehyde-fixed periodontal bacteria did not induce the proliferation of PBL at any time during a 1-week culture period. Cytotoxicity peaked on day 1 of culture, although modest but significant cytotoxicity was noted on day 3 with some bacteria. By day 7, cytotoxicity of cultures with bacteria was 10-fold less than that of IL-2 cultures. This finding suggests that cytotoxic effectors on day 3 did not have to proliferate to be cytolytic and contrasts with the observations of Grimm and Wilson (9) , who demonstrated that activation of lymphokine-activated killers requires proliferation. These data also contrast with the findings of Banck and Forsgren (2), who demonstrated that many bacteria, including gram-negative bacteria, were primarily mitogenic for B cells and unseparated PBL. However, they found a maximal response at 3 to 4 days and did not test any of the bacteria used in this study. Miller et al. (16) also found that only non-T cells are stimulated by LPS from gram-negative bacteria, but in their study, peak stimulation occurred at 7 to 9 days of culture.
LPS (endotoxins) isolated from gram-negative periodontal bacteria, including some of the bacteria tested in this study, have been shown to be potent activators of NK activity (Lindemann et al., in press ). Therefore, surface-bound LPS on glutaraldehyde-fixed bacteria was considered a likely candidate to provide the activation stimulus to lymphocyt6s in culture. It has been demonstrated that the anitibiotic PB readily binds to LPS and cail neutralize endotoxin toxicity (17) . It has been shown that PB modifies the human fleutrophil response to endotoxin (4) . The addition of 100 ,ug of PB per ml per bacteria-lymphocyte culture abrogated the inductive effects of all bacteria tested. Culture supernatants collected after 24 h of incubation with A. actinomycetemcomitans Y4 also activated autologous PBL; however, PB eliminated this response completely. These data again suggest that IL-2 measured in supernatants was not totally responsible for NK activation and that the major activation signal was provided by LPS. However, there may be a direct LPS enhancement plus secondary cytolytic activation by IL-2. Also, whole LPS or LPS moieties are apparently shed by some fixed bacteria into the culture media, and these LPS or LPS moieties can elicit a similar activation response. Transmission electron microscopy has demonstrated that large numbers of LPS vesicles are found in the external environment of A. actinomycetemcomitans (12) . This finding is contrary to the observations of Tarkkanen et al. (29) with LPS from Salmonella bacteria. They found that LPS blocks activation by whole bacteria. However, there are differences between enteric and oral bacteria that could be responsible for the apparent contradiction. A. actinomycetemcomitans is relatively low in 3-deoxy-D-manno-2-octulosonic acid, and its 0-antigen chain length exhibits far less heterogeneity than that from enteric bacteria does (10; C. I. Hoover and S. J. Fisher, J. Dent. Res. 64:371, 1985) .
The mechanism whereby LPS activates NK cells is unknown. Salata et al. (26) The significance of bacterial activation has not been completely established. The bactericidal activity of NK cells or bacterium-activated cells against enteric bacteria was not found to be significant (29) . It is likely that modest direct killing of bacteria occurs after NK activation (18), but certainly not to the degree that neutrophils kill bacteria. Perhaps NK cells provide a secondary defense against microbial agents. It is intriguing to speculate on the negative aspects of NK activation. Bacterium-or virus-activated NK cells may kill innocent bystander host cells by the release of cytotoxic factors (32) or by direct binding and killing (14) . Additionally, as it is proposed that NK cells regulate immune responses by eliminating antigen-presenting cells (1) , activation of NK cells may impair an effective antibody response.
In conclusion, this study has demonstrated that gramnegative whole bacteria fixed with glutaraldehyde activated NK cells by bacterial cell surface LPS. This activation induced the modest release of IL-2 which was not shown to be responsible for the majority of cytotoxicity.
